Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers

NCT05195723 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: WP1122
DRUG: Placebo

Sponsor

Moleculin Biotech, Inc.